Cargando…
Cardiovascular disease and chimeric antigen receptor cellular therapy
Chimeric antigen receptor T-cell (CAR T) therapy is a revolutionary personalized therapy that has significantly impacted the treatment of patients with hematologic malignancies refractory to other therapies. Cytokine release syndrome (CRS) is a major side effect of CAR T therapy that can occur in 70...
Autores principales: | Rao, Anjali, Stewart, Andrew, Eljalby, Mahmoud, Ramakrishnan, Praveen, Anderson, Larry D., Awan, Farrukh T., Chandra, Alvin, Vallabhaneni, Srilakshmi, Zhang, Kathleen, Zaha, Vlad G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538377/ https://www.ncbi.nlm.nih.gov/pubmed/36211558 http://dx.doi.org/10.3389/fcvm.2022.932347 |
Ejemplares similares
-
Gender Differences in Diagnosis, Prevention, and Treatment of Cardiotoxicity in Cardio-Oncology
por: Simek, Shawn, et al.
Publicado: (2022) -
Chimeric Antigen Receptors Expand the Repertoire of Antigenic Macromolecules for Cellular Immunity
por: Keane, John T., et al.
Publicado: (2021) -
Chimeric antigen receptor-T cell therapy-related cardiotoxicity in adults and children cancer patients: A clinical appraisal
por: Camilli, Massimiliano, et al.
Publicado: (2023) -
Cardiovascular Magnetic Resonance in Early Detection of Radiation Associated Cardiotoxicity With Chest Radiation
por: Vallabhaneni, Srilakshmi, et al.
Publicado: (2022) -
Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies
por: Polgárová, Kamila, et al.
Publicado: (2022)